Daiwa Securities Group
SNDX icon

Daiwa Securities Group’s Syndax Pharmaceuticals SNDX Stock Holding History

Daiwa Securities Group’s Portfolio SNDX Stock Details SNDX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-244
Closed -$5K – 1407
2025
Q4 		$5K Sell
244
-70
-22% -$1.22K ﹤0.01% 1240
2025
Q3 		$5K Hold
314
– – ﹤0.01% 1208
2025
Q2 		$3K Hold
314
– – ﹤0.01% 1198
2025
Q1 		$4K Hold
314
– – ﹤0.01% 1154
2024
Q4 		$4K Hold
314
– – ﹤0.01% 1178
2024
Q3 		$6K Hold
314
– – ﹤0.01% 1162
2024
Q2 		$6K Hold
314
– – ﹤0.01% 1192
2024
Q1 		$7K Buy
314
+72
+30% +$1.61K ﹤0.01% 1188
2023
Q4 		$5K Hold
242
– – ﹤0.01% 1208
2023
Q3 		$4K Hold
242
– – ﹤0.01% 1179
2023
Q2 		$5K Hold
242
– – ﹤0.01% 1187
2023
Q1 		$5K Hold
242
– – ﹤0.01% 1159
2022
Q4 		$6K Buy
242
+75
+45% +$1.75K ﹤0.01% 1146
2022
Q3 		$4K Hold
167
– – ﹤0.01% 1182
2022
Q2 		$3K Hold
167
– – ﹤0.01% 1211
2022
Q1 		$3K Hold
167
– – ﹤0.01% 1230
2021
Q4 		$4K Hold
167
– – ﹤0.01% 1230
2021
Q3 		$3K Buy
167
+74
+80% +$1.23K ﹤0.01% 1227
2021
Q2 		$2K Hold
93
– – ﹤0.01% 1156
2021
Q1 		$2K Buy
93
+16
+21% +$361 ﹤0.01% 1162
2020
Q4 		$2K Buy
+77
New +$1.6K ﹤0.01% 1138
2018
Q4 		– Sell
-135
Closed -$1K – 1178
2018
Q3 		$1K Hold
135
– – ﹤0.01% 1149
2018
Q2 		$1K Hold
135
– – ﹤0.01% 1168
2018
Q1 		$2K Buy
+135
New +$1.43K ﹤0.01% 1131

Other funds holding SNDX

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
KCM
Kynam Capital Management Princeton, New Jersey $1.62B AUM 138.67% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
EP
Eversept Partners New York $1.9B AUM 121.13% 1-Year Est. Return
KCM
Kingdon Capital Management New York $911M AUM 51.11% 1-Year Est. Return
HRCM
Hood River Capital Management Palm Beach Gardens, Florida $9.98B AUM 145.42% 1-Year Est. Return

Daiwa Securities Group's SNDX Position: Q1 2026 in Review

Daiwa Securities Group sold out of Syndax Pharmaceuticals (SNDX) in Q1 2026, closing a stake of 244 shares — an estimated $5K sold.

Daiwa Securities Group first reported a position in SNDX in Q1 2018 and held it in 24 quarters. The position peaked at $7K in Q1 2024. 246 funds tracked by Wall St. Rank hold SNDX as of Q1 2026.

  • Daiwa Securities Group reported no remaining Syndax Pharmaceuticals position as of Q1 2026 after selling out during the quarter.
  • Daiwa Securities Group sold 244 Syndax Pharmaceuticals shares in Q1 2026, an estimated $5K.
  • Daiwa Securities Group first reported a position in Syndax Pharmaceuticals in Q1 2018 and held it in 24 quarters.
  • Daiwa Securities Group's Syndax Pharmaceuticals position peaked at $7K in Q1 2024.
  • 246 funds tracked by Wall St. Rank held Syndax Pharmaceuticals as of Q1 2026.

Based on Daiwa Securities Group's 13F filing for Q1 2026, filed 13 May 2026.